We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Omega Diagnostics Group Plc | LSE:ODX | London | Ordinary Share | GB00B1VCP282 | ORD 4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 2.20 | 2.00 | 2.40 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMODX
RNS Number : 1870O
Omega Diagnostics Group PLC
08 June 2022
OMEGA DIAGNOSTICS GROUP PLC
("Omega" or the "Company" or the "Group")
PDMR/Director Dealing
Omega (AIM: ODX), the specialist medical diagnostics company focused on industry-leading Health & Nutrition and Global Health products, announces that, following the general meeting held on 6 June 2022 and Admission on 8 June 2022, the following Directors participated in the Fundraising and their resultant holdings are detailed in the table below.
Director Board Position Number of Amount (GBP) Resultant Resultant Subscription holding percentage Shares at holding of the Issue Enlarged Price Issued Share Capital Simon Douglas(1) Chairman 500,000 2 0,000 500,000 0.21% ---------------- -------------- ------------- ---------- -------------- Jag Grewal(2) CEO 500,000 20,000 735,746 0.31% ---------------- -------------- ------------- ---------- -------------- Chris Lea(3) CFO 500,000 20,000 500,000 0.21% ---------------- -------------- ------------- ---------- -------------- Non-Executive Jeremy Millard(4) Director 500,000 20,000 1,025,000 0.43% ---------------- -------------- ------------- ---------- --------------
Capitalised terms not otherwise defined in the text of this announcement have the meanings given to them in the Company's circular dated 13 May 2022.
Contacts:
Omega Diagnostics Group PLC www.omegadx.com Jag Grewal, Chief Executive Officer via Walbrook PR Chris Lea, Chief Financial Officer finnCap Ltd Tel: 020 7220 0500 Geoff Nash/Edward Whiley/George Dollemore (Corporate Finance) Alice Lane/ Harriet Ward (ECM) Walbrook PR Limited Tel: 020 7933 8780 or omega@walbrookpr.com Paul McManus Mob: 07980 541 893 Lianne Applegarth Mob: 07584 391 303 Sam Allen Mob: 07502 558 258
About Omega Diagnostics Group PLC
Omega manufactures and distributes high quality in-vitro diagnostic products for use in hospitals, clinics, laboratories and healthcare practitioners in over 70 countries and specialise in the areas of health and nutrition and global health.
www.omegadx.com
Notification of transactions of persons discharging managerial responsibilities and persons closely associated with them
1 Details of the person discharging managerial responsibilities / person closely associated a) Name 1) Simon Douglas 2) Jag Grewal 3) Chris Lea 4) Jeremy Millard ---------------------------- ---------------------------------- 2 Reason for the notification ---------------------------------------------------------------- a) Position/status 1) Chairman 2) Chief Executive Officer 3) Chief Financial Officer 4) Non-Executive Director ---------------------------- ---------------------------------- b) Initial notification Initial Notification /Amendment ---------------------------- ---------------------------------- 3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ---------------------------------------------------------------- a) Name Omega Diagnostics Group Plc ---------------------------- ---------------------------------- b) LEI 2138007U9P4BTZTYIR92 ---------------------------- ---------------------------------- 4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted ---------------------------------------------------------------- a) Description of Ordinary Shares of 4 pence each the financial instrument, type of instrument ISIN: GB00B1VCP282 Identification code ---------------------------- ---------------------------------- b) Nature of the transaction Purchase of Shares ---------------------------- ---------------------------------- c) Price(s) and volume(s) Price(s) Volume(s) 1) GBP0.04 500,000 2) GBP0.04 500,000 3) GBP0.04 500,000 4) GBP0.04 500,000 ---------------------------- ---------------------------------- d) Aggregated information N/A - single transaction for -Aggregated volume each Director or PCA - Price ---------------------------- ---------------------------------- e) Date of the transaction 6 May 2022 ---------------------------- ---------------------------------- f) Place of the transaction London Stock Exchange (AIM) ---------------------------- ----------------------------------
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHBKFBQBBKDAAK
(END) Dow Jones Newswires
June 08, 2022 08:48 ET (12:48 GMT)
1 Year Omega Diagnostics Chart |
1 Month Omega Diagnostics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions